Literature DB >> 29451051

Influence of surgical approach on complication risk in primary total hip arthroplasty.

Larry E Miller1, Joseph S Gondusky2, Atul F Kamath3, Friedrich Boettner4, John Wright5, Samir Bhattacharyya5.   

Abstract

Background and purpose - Systematic comparisons of anterior approach (A) versus posterior approach (P) in primary total hip arthroplasty (THA) have largely focused on perioperative outcomes. In this systematic review with meta-analysis, we compared complication risk of A versus P in studies of primary THA with at least 1-year mean follow-up. Patients and methods - We performed a systematic review of prospective and retrospective studies with at least 1-year mean follow-up that reported complications of A and P primary THA. Complications included infection, dislocation, reoperation, thromboembolic event, heterotopic ossification, wound complication, fracture, and nerve injury. Random effects meta-analysis was used for all outcomes. Complication risk was reported as rate ratio (RR) to account for differential follow-up durations; values >1 indicated higher complication risk with A and values <1 indicated lower risk with A. Results - 19 studies were included; 15 single-center comparative studies with 6,620 patients (2,278 A; 4,342 P) and 4 multicenter registries with 157,687 patients (18,735 A; 138,952 P). Median follow-up was 16 (12-64) months) with A and 18 (12-110) months with P. Anterior approach was associated with lower rate of infection (RR =0.55, p = 0.002), dislocation (RR =0.65, p = 0.03), and reoperation (RR =0.84, p < 0.001). No statistically significant differences were observed in rate of thromboembolic event (RR =0.59, p = 0.5), heterotopic ossification (RR =0.63, p = 0.1), wound complication (RR =0.93, p = 0.8), or fracture (RR =1.0, p = 0.9). There was a higher rate of patient-reported nerve injury with A (RR =2.3, p = 0.01). Interpretation - Comparing A with P in primary THA, A was associated with lower risk of reoperation, dislocation, and infection, but higher risk of patient-reported nerve injury.

Entities:  

Mesh:

Year:  2018        PMID: 29451051      PMCID: PMC6055783          DOI: 10.1080/17453674.2018.1438694

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


The durability of total hip arthroplasty (THA) is excellent with 10-year survivorship exceeding 90% (Hailer et al. 2015, Makela et al. 2014). All standard approaches to the hip have been shown to be safe and effective, with certain advantages and disadvantages of each approach (Mjaaland et al. 2017). While the anterior approach (A) has been increasingly used in the United States, little is known about the safety of the A relative to other common surgical approaches. Several groups (Higgins et al. 2015, Meermans et al. 2017, Putananon et al. 2018) have performed systematic reviews comparing the A with the posterior approach (P) in primary THA. However, follow-up durations of the included studies varied widely, with most studies having less than 1-year follow-up. Comparative safety evaluation of these surgical techniques over a longer period is warranted. The purpose of this systematic review with meta-analysis was to compare the complication risk of A versus P in studies with at least 1-year mean follow-up.

Methods

Literature search and data extraction

In accordance with the PRISMA guidelines, we searched MEDLINE and EMBASE for comparative studies of primary THA performed using the A or P. Therapeutic search terms consisting of THA and total hip arthroplasty were combined with the following surgical approach-specific search terms: anterior, direct, posterior, posterolateral, and Smith-Petersen. We also manually searched the Directory of Open Access Journals (DOAJ), Google Scholar, and the reference lists of included papers and relevant systematic reviews. No language or date restrictions were applied to the searches. The final search was conducted on June 30, 2017. Study eligibility was determined by 2 independent researchers (LM, DF). Disagreements were resolved by discussion. Main inclusion criteria included comparison of A versus P in primary THA, predominant diagnosis of osteoarthritis, mean follow-up duration at least 1 year, and extractable complication data. Titles and abstracts were initially screened to exclude review articles, commentaries, letters, case reports, and obviously irrelevant studies. Full-texts of the remaining articles were retrieved and reviewed. Studies were excluded if patients received revision or bilateral THA. When multiple studies included overlapping series of patients, only the study with the largest sample size was included. Data were independently extracted from eligible peer-reviewed articles by the same 2 researchers. Data discrepancies were resolved by discussion.

Definitions and outcomes

When data were reported at multiple intervals during follow-up, the final value was extracted for analysis. Complications included infection, dislocation, reoperation (for any reason), thromboembolic event, heterotopic ossification, wound complication, fracture, and nerve injury. To account for differential follow-up durations, complication data were extracted by determining the number of events and then calculating the number of person-years in each group to determine incidence rates. Risk of bias in each study was assessed with the Cochrane Collaboration tool, which included evaluations of sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other sources of bias (Higgins et al. 2011).

Data analysis

We assumed heterogeneous effects among studies a priori and conservatively applied a random effects model for all outcomes. Denominators were adjusted to include the number of patients or hips, as appropriate. The rate ratio (RR) was the effect size statistic of interest, which indicates the ratio of incidence rates (events per person-year) between A and P. A RR value >1 indicates higher complication incidence rate with A and a value <1 indicates lower complication incidence rate with A. For each complication, the RR and 95% confidence interval (CI) were calculated in each study and pooled among all studies. Inconsistency in complication risk among studies was quantified with the I2 statistic; values of ≤25%, 50%, and ≥75% represented low, moderate, and high inconsistency, respectively (Higgins et al. 2003). Publication bias was visually assessed with funnel plots (not shown) and quantitatively assessed using Egger’s regression test. Post hoc random effects meta-regression using the Knapp–Hartung method (Knapp and Hartung 2003) was performed to assess the possible influence of study design, median surgery year, inclusion of learning cases, and follow-up duration on complication risk. P-values were 2-sided with a significance level <0.05. Analyses were performed using Comprehensive Meta-analysis (version 3.3, Biostat, Englewood, NJ, USA).

Funding and potential conflicts of interest

This work was supported by DePuy Synthes (Raynham, MA, USA). LM received a research grant from DePuy Synthes for data analysis. JW and SB are employees of DePuy Synthes. JG, AK, and FB declare no conflict of interest in this work.

Results

Study selection

After screening 340 records for eligibility, 19 studies were included in this review, including 15 single-center comparative studies with 6,620 patients (2,278 A; 4,342 P) and 4 multicenter registries with 157,687 patients (18,735 A; 138,952 P). Primary reasons for study exclusion included mean follow-up less than 1 year (27 studies), complications not reported (25 studies), and no comparison of A with P (20 studies) (Figure).

Study and patient characteristics

This review included 4 randomized controlled trials, 1 prospective nonrandomized study, 10 retrospective studies, and 4 multicenter registries. Surgeries in each group occurred during the same period in 11 studies. In 7 studies, learning curve cases comprised some or all of the A group. Median follow-up duration was 16 months (range: 12–64 months) with A and 18 months (range: 12–110 months) with P. Comparing patients treated with A versus P, baseline patient characteristics were well matched for age (median 63 years per group), female sex (median 60% versus 58%), and BMI (median 28 per group) (Table 1). The primary risks of bias were attributable to inclusion of retrospective nonrandomized studies (Table 2).
Table 1.

Study and patient characteristics

StudyTreatmentParallel treatmentLearning casesMean follow-up,monthsSample sizebMean age,yearsFemale, %Mean BMI
StudydesignaperiodperiodincludedAPAPAPAPAP
Comparative studies:
 Balasubramaniam et al. 2016RN2006–2011NoYes12125042635750673130
 Barrett et al. 2013RCT2010–2011YesNo12124344616333573129
 Batailler et al. 2017RN2013–2015YesYes1414201101727465652628
 Fransen et al. 2016RN2012YesYes12124538646367632528
 Luo et al. 2016RCT2014YesNo14145252626467582324
 Malek et al. 2016RN2010–2014YesNo1818265183717056532929
 Newman et al. 2016RNNRNR2424235120635954572934
 Rathod et al. 2014RN2007–2011NoNo1630286293626155572626
 Rodriguez et al. 2014PN2010YesNo12126060605953572728
 Sugano et al. 2009RN2005–2007NoNR24243339565788922323
 Taunton et al. 2014RCT2012YesNo12122727626656522829
 Tripuraneni et al. 2016RN2012–2015YesYes14136666606061612828
 Tsukada and Wakui 2015RN2000–2009NoNR64110139177676290832324
 Watts et al. 2015RN2010–2014NRNR12127163,040646251512930
 Zhang et al. 2006RCT2002–2004YesNR2020606061635853c
Registries
 Amlie et al. 2014RN2008–2010YesNo243042142167666964
 Mjaaland et al. 2017RN2008–2013YesYes52522,0175,96167656765
 Sheth et al. 2015RN2001–2011NoYes36361,85131,747656660582829
 Zijlstra et al. 2017RN2007–2015NoYes404014,446100,8236868

A = anterior approach; P = posterior approach; NR = not reported

Study design: PN = prospective nonrandomized; RCT = randomized controlled trial; RN = retrospective nonrandomized.

Reported as number of patients or hips.

All patients with BMI ≤27 kg/m2.

Table 2.

Cochrane risk of bias assessment

Study and patient characteristics A = anterior approach; P = posterior approach; NR = not reported Study design: PN = prospective nonrandomized; RCT = randomized controlled trial; RN = retrospective nonrandomized. Reported as number of patients or hips. All patients with BMI ≤27 kg/m2. Cochrane risk of bias assessment

Complications

The A was associated with lower rates of infection (RR =0.55, p = 0.002 from 7 studies), dislocation (RR =0.65, p = 0.03 from 11 studies), and reoperation (RR =0.84, p < 0.001 from 16 studies). In a subgroup analysis of infection, the rate of superficial (RR =0.47, p = 0.5) and deep infection (RR =0.23, p = 0.1) remained low with A, but neither was statistically significant. When explicitly reported, the most common reasons for reoperation were aseptic loosening, dislocation, fracture, and infection in the A group and dislocation, aseptic loosening, infection, and fracture in the P group. No statistically significant differences were observed in the rate of thromboembolic event (RR =0.59, p = 0.5 from 4 studies), heterotopic ossification (RR =0.63, p = 0.1 from 4 studies), wound complication (RR =0.93, p = 0.8 from 5 studies), or fracture (RR =1.0, p = 0.9 from 10 studies). Most fracture reports were of intraoperative periprosthetic fractures; however, type and time to fracture was not consistently reported. There was a higher rate of patient-reported nerve injury with A vs. P (RR =2.3, p = 0.01 from 2 studies). Nerve injuries were described as patient-reported sensory deficit (Luo et al. 2016) or patient-reported nerve injury with no distinction between sensory and motor involvement (Amlie et al. 2014). For each complication, heterogeneity among studies was low and publication bias was not evident (Table 3).
Table 3.

Complication rates with anterior versus posterior approach in primary total hip arthroplasty

Event rate per 100 person-years
OutcomeStudiesAPEffect size Rate ratio (95% CI)ap-valueHeterogeneity (I2), %Publication bias (Egger’s p-value)
Infection70.20.40.55 (0.38–0.80)0.00200.5
Thromboembolic event40.51.10.59 (0.14–2.43)0.500.2
Heterotopic ossification41.52.30.63 (0.35–1.13)0.100.3
Dislocation110.20.20.65 (0.44–0.95)0.03170.5
Reoperation160.60.70.84 (0.75–0.93)< 0.00101.0
Wound51.71.90.93 (0.54–1.63)0.800.4
Fracture100.30.11.02 (0.75–1.38)0.900.2
Patient-reported nerve injury23.01.32.31 (1.22–4.39)0.010b

Notes: A = anterior approach; P = posterior approach.

Rate ratio >1 indicates higher complication incidence rate with anterior approach; rate ratio <1 indicates lower complication incidence rate with anterior approach.

Inadequate number of studies to calculate value.

Complication rates with anterior versus posterior approach in primary total hip arthroplasty Notes: A = anterior approach; P = posterior approach. Rate ratio >1 indicates higher complication incidence rate with anterior approach; rate ratio <1 indicates lower complication incidence rate with anterior approach. Inadequate number of studies to calculate value.

Post hoc meta-regression

Post hoc meta-regression was performed to assess the possible influence of study design, median surgery year, inclusion of learning cases, and follow-up duration on complication risk. No covariate was statistically significantly associated with the risk of any complication. In comparative studies, there was no statistically significant difference between A vs. P in the rate of any complication. In registries, the rate of patient-reported nerve injury was higher with A while the rates of infection and reoperation were lower with A (Table 4).
Table 4.

Subgroup analysis of study design on complication rates with anterior versus posterior approach in primary total hip arthroplasty

Comparative studies
Registries
OutcomeStudiesRate ratio (95% CI)aStudiesRate ratio (95% CI)ap-valueb
Infection60.66 (0.16–2.7)10.55 (0.37–0.80)0.8
Thromboembolic event40.59 (0.14–2.4)0
Heterotopic ossification30.58 (0.30–1.2)10.81 (0.24–2.7)0.6
Dislocation80.55 (0.17–1.8)30.74 (0.39–1.4)0.7
Reoperation121.03 (0.60–1.8)40.83 (0.72–0.95)0.5
Wound50.93 (0.54–1.6)0
Fracture91.7 (0.79–3.7)10.93 (0.66–1.3)0.2
Patient-reported nerve injury15.0 (0.24–104)12.2 (1.2–4.3)0.6

Rate ratio >1 indicates higher complication incidence rate with anterior approach; RR <1 indicates lower complication incidence rate with anterior approach.

Comparison of rate ratio in comparative studies versus registries, derived from Knapp– Hartung random effects meta-regression model.

Subgroup analysis of study design on complication rates with anterior versus posterior approach in primary total hip arthroplasty Rate ratio >1 indicates higher complication incidence rate with anterior approach; RR <1 indicates lower complication incidence rate with anterior approach. Comparison of rate ratio in comparative studies versus registries, derived from Knapp– Hartung random effects meta-regression model.

Discussion

We conducted a systematic review and meta-analysis of comparative studies of A versus P primary THA with at least 1-year mean follow-up. An anterior approach was associated with a lower risk of reoperation, dislocation, and infection, but higher risk of patient-reported nerve injury. No difference was seen in the rate of thromboembolic event, heterotopic ossification, wound complication, or fracture. While heterogeneity or publication bias was not evident for any outcome, the possibility of such influences cannot be ruled out given the small number of studies reporting each complication. A criticism of the A in primary THA is the presence of a learning curve, during which complication rates may be elevated. In an analysis of over 5,000 THA procedures, 50 or more A procedures were required to overcome the learning curve (de Steiger et al. 2015). In a single-surgeon experience with the first 500 A cases, the most dramatic reduction in complication rates occurred after the first 100 cases (Hartford and Bellino 2017). We identified no substantial influence of learning case inclusion on complication rates in meta-regression although this analysis was limited since it was not possible to determine the percentage of the entire sample comprising learning cases. We identified a higher rate of patient-reported nerve injury with A. In the study of Amlie et al. (2014), nerve injury was self-reported in 5.9% of A patients at 24 months follow-up and 3.3% of P patients at 30 months follow-up; however, there was no distinction between sensory or motor involvement. In another comparative study (Luo et al. 2016), sensory deficit was 3.8% with A and 0% with P at 14 months’ follow-up. While comparative nerve injury data were limited to these 2 studies, a high incidence of sensory deficit with A has been reported in other studies (Bhargava et al. 2010, Goulding et al. 2010). This is primarily attributable to likely iatrogenic injury of the lateral cutaneous femoral nerve. Despite the higher patient-reported nerve injury rate with A, long-term functional limitations or higher reoperation rates are unlikely with these events based on the findings from other studies (Bhargava et al. 2010, Goulding et al. 2010). In a meta-analysis comparing A and P (Higgins et al. 2015), there were no group differences in risk of intraoperative fracture and lower risk of dislocation with A. More recently, a systematic review compared anterior, posterior, and lateral approaches in primary THA (Meermans et al. 2017). In that review, complications were not systematically evaluated although the authors concluded that there were similar rates of complications between surgical approaches. In a network meta-analysis of randomized controlled trials (Putananon et al. 2018), complication risk was reported to be lower with P vs. A (1.0% vs. 1.4%); however, specific complications were not described. Among these reviews, follow-up duration varied considerably and was generally less than 1 year. Key differences in our meta-analysis are inclusion of only those studies with mean follow-up of at least 1 year, reporting of multiple specific complications, and statistical adjustment to account for differential follow-up periods among studies. Several aspects of our meta-analysis are novel including the longest duration follow-up of any A versus P review and a comprehensive assessment of complication rates. There are also several limitations. First, despite the longest mean follow-up of any review on this topic, it must be acknowledged that data derived from 16 (A) to 18 (P) months median follow-up must be considered preliminary. Further, while the RR statistic allows for group comparison of event rates on a common scale (per person-year), event rates that are non-constant with respect to time may complicate interpretation of these results. Second, while osteoarthritis was the predominant diagnosis in each study, reporting of THA indications was inconsistent and may have confounded outcomes. Third, due to the small number of studies reporting certain complications, some complication estimates reported in this review may change with the addition of data by future studies. Further, the influence of study design on complication rates should be interpreted cautiously given the small number of studies for subgroup comparisons. Fourth, complication reporting was generally inconsistent among studies. Adherence to standardized complication reporting guidelines would greatly improve data transparency and consistency in the THA literature. Fifth, no conclusions regarding complication risk with anterolateral or lateral approaches in THA may be derived from this review. Finally, 14 of 19 included studies were retrospective in nature, which are inherently prone to bias. In summary, comparing A with P in primary THA, A was associated with a lower rate of reoperation, dislocation, and infection, but a higher rate of patient-reported nerve injury. Conception and design: LM, SB. Data collection: LM. Data analysis: LM. Writing the article: LM. Critical revision of the article: LM, JG, AK, FB, JW, SB The authors would like to thank David Fay, PhD for assistance with literature review. Acta thanks Johan Kärrholm and other anonymous reviewers for help with peer review of this study PRISMA study flow diagram.
  30 in total

1.  Implant Survival After Minimally Invasive Anterior or Anterolateral Vs. Conventional Posterior or Direct Lateral Approach: An Analysis of 21,860 Total Hip Arthroplasties from the Norwegian Arthroplasty Register (2008 to 2013).

Authors:  Knut Erik Mjaaland; Svein Svenningsen; Anne Marie Fenstad; Leif I Havelin; Ove Furnes; Lars Nordsletten
Journal:  J Bone Joint Surg Am       Date:  2017-05-17       Impact factor: 5.284

2.  Direct anterior approach versus posterolateral approach in total hip arthroplasty : one surgeon, two approaches.

Authors:  B Fransen; M Hoozemans; S Vos
Journal:  Acta Orthop Belg       Date:  2016-08       Impact factor: 0.500

3.  The learning curve for the direct anterior approach for total hip arthroplasty: a single surgeon's first 500 cases.

Authors:  James M Hartford; Michael J Bellino
Journal:  Hip Int       Date:  2017-02-17       Impact factor: 2.135

4.  Functional and clinical outcomes following anterior hip replacement: a 5-year comparative study versus posterior approach.

Authors:  Umatheepan Balasubramaniam; Michelle Dowsey; Francis Ma; Anthony Dunin; Peter Choong
Journal:  ANZ J Surg       Date:  2016-05-27       Impact factor: 1.872

5.  High Risk of Wound Complications Following Direct Anterior Total Hip Arthroplasty in Obese Patients.

Authors:  Chad D Watts; Matthew T Houdek; Eric R Wagner; Peter K Sculco; Brian P Chalmers; Michael J Taunton
Journal:  J Arthroplasty       Date:  2015-06-12       Impact factor: 4.757

6.  Does the direct anterior approach in THA offer faster rehabilitation and comparable safety to the posterior approach?

Authors:  José A Rodriguez; Ajit J Deshmukh; Parthiv A Rathod; Michelle L Greiz; Prashant P Deshmane; Matthew S Hepinstall; Amar S Ranawat
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

7.  Worse patient-reported outcome after lateral approach than after anterior and posterolateral approach in primary hip arthroplasty. A cross-sectional questionnaire study of 1,476 patients 1-3 years after surgery.

Authors:  Einar Amlie; Leif I Havelin; Ove Furnes; Valborg Baste; Lars Nordsletten; Oystein Hovik; Sigbjorn Dimmen
Journal:  Acta Orthop       Date:  2014-06-23       Impact factor: 3.717

8.  Effect of femoral head size and surgical approach on risk of revision for dislocation after total hip arthroplasty.

Authors:  Wierd P Zijlstra; Bas De Hartog; Liza N Van Steenbergen; B Willem Scheurs; Rob G H H Nelissen
Journal:  Acta Orthop       Date:  2017-04-25       Impact factor: 3.717

9.  Lower Dislocation Rate Following Total Hip Arthroplasty via Direct Anterior Approach than via Posterior Approach: Five-Year-Average Follow-Up Results.

Authors:  Sachiyuki Tsukada; Motohiro Wakui
Journal:  Open Orthop J       Date:  2015-05-15

10.  Hydroxyapatite coating does not improve uncemented stem survival after total hip arthroplasty!

Authors:  Nils P Hailer; Stergios Lazarinis; Keijo T Mäkelä; Antti Eskelinen; Anne M Fenstad; Geir Hallan; Leif Havelin; Søren Overgaard; Alma B Pedersen; Frank Mehnert; Johan Kärrholm
Journal:  Acta Orthop       Date:  2014-09-01       Impact factor: 3.717

View more
  24 in total

1.  Perioperative complications and causes of 30- and 90-day readmission after direct anterior approach primary total hip arthroplasty.

Authors:  Eric Sali; Jean-Luc Marmorat; Fabrice Gaudot; Christophe Nich
Journal:  J Orthop       Date:  2019-08-10

2.  Effect of predictive nursing on postoperative rehabilitation and complications of patients undergoing hip replacement and maintenance hemodialysis.

Authors:  Mingzhi Lin; Fang Zhang
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  Direct anterior approach in total hip arthroplasty: influence of stem length on clinical and radiological outcomes at medium-term follow-up.

Authors:  Salvatore Risitano; Alice Piccato; Federico Fusini; Lorenzo Rissolio; Marco Marcarelli; Gianmarco Bosa; Pier Francesco Indelli
Journal:  Musculoskelet Surg       Date:  2022-08-19

4.  Institutional arthroplasty registry: what is the minimum acceptable dataset to be included in your hospital? Recommendations from a single-country national consensus using the Delphi method.

Authors:  Guillermo A Bonilla; Beatriz E Montoya; Victoria E Restrepo; Miguel M Gomez; Alfredo A Sánchez; Jose I Sánchez; Hugo A Rodríguez; Jairo A Rincón; Antonio L Solano; Diego Cardona; Saúl L Martínez; Alejandro López; Jose L Moore
Journal:  Int Orthop       Date:  2020-11-15       Impact factor: 3.075

5.  Effect of continuous nursing combined with salcatonin on postoperative pains in elderly patients after hip replacement.

Authors:  Liyu Zhu; Lin Li; Binyan Yin; Xian Jiang; Huanchuan Peng; Xiaomin Hou
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

6.  A novel single myocapsular sleeve (SMS) repair technique to reduce dislocation in posterior approach to the hip: A clinico-radiographic study.

Authors:  Chandra Shekhar Yadav; Samarth Mittal; Swapnil Singh; Shivanand Gamanagatti; Sumit Anand; Ashok Kumar
Journal:  J Clin Orthop Trauma       Date:  2019-03-22

Review 7.  The role of the femoral component orientation on dislocations in THA: a systematic review.

Authors:  Joost H J van Erp; Thom E Snijders; Harrie Weinans; René M Castelein; Tom P C Schlösser; Arthur de Gast
Journal:  Arch Orthop Trauma Surg       Date:  2021-06-08       Impact factor: 2.928

8.  Nerve palsy, dislocation and revision rate among the approaches for total hip arthroplasty: a Bayesian network meta-analysis.

Authors:  F Migliorini; A Trivellas; J Eschweiler; A Driessen; F Lessi; M Tingart; P Aretini
Journal:  Musculoskelet Surg       Date:  2020-05-05

9.  Late Anterior Prosthetic Hip Dislocation Due to Yoga.

Authors:  Andrew D Posner; Afshin A Anoushiravani; Hamza Murtaza; Jared Roberts
Journal:  Arthroplast Today       Date:  2021-03-04

10.  Risk factors and modes of failure in the modern dual mobility implant. A systematic review and meta-analysis.

Authors:  Fu-Yuan Pai; Hsuan-Hsiao Ma; Te-Feng Arthur Chou; Tsan-Wen Huang; Kuo-Chin Huang; Shang-Wen Tsai; Cheng-Fong Chen; Wei-Ming Chen
Journal:  BMC Musculoskelet Disord       Date:  2021-06-14       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.